Paper
24 March 2023 Design of a novel CAR T system targeting glioblastoma
Yifei Qiu, Lei Huang, Aojie Guo, Qiujie Wang, Liyuan Liu
Author Affiliations +
Proceedings Volume 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022); 126111L (2023) https://doi.org/10.1117/12.2669343
Event: International Conference on Biological Engineering and Medical Science (ICBioMed2022), 2022, Oxford, United Kingdom
Abstract
Glioblastoma is considered one of the most severe malignancies in human adults. Research focusing on glioblastoma has continued for decades, with a limited number of treatments undergoing clinical trials. Recently, T cells bearing chimeric antigen receptors (CARs) have been researched intensely as a promising immunotherapeutic approach, yet dilemmas such as antigen escape, unspecific activation and immune inhibition from tumour cells are limiting their feasibility. In this work, based on the latest reports of advanced CAR T system, we designed a novel CAR T system to treat glioblastoma integrated synthetic Notch receptor, anti-p32 CAR, nuclear receptor subfamily 4A inhibition element and oxygen-dependent degradation domain. It will be activated with a gating strategy and stepwise method to promote its specificity, security and cytotoxicity, which makes it a potentially improved treatment of glioblastoma in the future.
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Yifei Qiu, Lei Huang, Aojie Guo, Qiujie Wang, and Liyuan Liu "Design of a novel CAR T system targeting glioblastoma", Proc. SPIE 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022), 126111L (24 March 2023); https://doi.org/10.1117/12.2669343
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Design and modelling

Proteins

Cancer

Oxygen

Mouse models

Tissues

Solids

Back to Top